Cryocompression for CIPN

Clinical trial NCT07064798 · RECRUITING

Trial details

NCT number: NCT07064798
Sponsor: Dana-Farber Cancer Institute
Status: RECRUITING
Phase: Not Applicable
Study type: INTERVENTIONAL

Chemotherapy-induced Peripheral Neuropathy Taxane-Induced Peripheral Neuropathy CIPN - Chemotherapy-Induced Peripheral Neuropathy

Start date: 2025-10-22
Primary completion: 2027-08-01
Enrollment: 50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.